Eton Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US29772L1089

SecurityETON / Eton Pharmaceuticals, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership500 shares
Latest Disclosed Value $ 8,455
Group One Trading, L.p. ownership in ETON / Eton Pharmaceuticals, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 500 shares of Eton Pharmaceuticals, Inc. (US:ETON) valued at $8,455 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 762 shares of Eton Pharmaceuticals, Inc.. This represents a change in shares of -34.38% during the quarter. The current value of the position is $14,450 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (ETON) in the form of stock options. The firm currently holds call options representing 100 of underlying shares valued at $1,691 USD and put options representing 400 of underlying shares valued at $6,764 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ETON / Eton Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F ETON PHARMACEUTICALS COM 29772L108 500 -262 -34.38 8 -50.00
2025-11-12 2025-09-30 13F ETON PHARMACEUTICALS COM 29772L108 762 762 17 0.0000
2025-08-14 2025-06-30 13F ETON PHARMACEUTICALS COM 29772L108 0 -634 -100.00 0 -100.00
2025-05-14 2025-03-31 13F ETON PHARMACEUTICALS COM 29772L108 634 634 8 0.0000
2025-05-14 2024-12-31 13F/A-1 ETON PHARMACEUTICALS COM 29772L108 0 -722 -100.00 0 -100.00
2025-02-14 2024-12-31 13F ETON PHARMACEUTICALS COM 29772L108 0 -722 0
2024-11-14 2024-09-30 13F ETON PHARMACEUTICALS COM 29772L108 722 722 4 0.0000
2023-02-09 2022-12-31 13F ETON PHARMACEUTICALS COM 29772L108 0 -608 -100.00 0 -100.00
2022-11-09 2022-09-30 13F ETON PHARMACEUTICALS COM 29772L108 608 -7,201 -92.21 1 -95.00 0.0000
2022-08-11 2022-06-30 13F ETON PHARMACEUTICALS COM 29772L108 7,809 -18,510 -70.33 20 -82.61 0.0000
2022-05-12 2022-03-31 13F ETON PHARMACEUTICALS COM 29772L108 26,319 -12,481 -32.17 115 -30.72 0.0001
2022-02-11 2021-12-31 13F ETON PHARMACEUTICALS COM 29772L108 38,800 24,756 176.27 166 133.80 0.0001
2021-11-12 2021-09-30 13F ETON PHARMACEUTICALS COM 29772L108 14,044 14,044 71 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ETON PHARMACEUTICALS COM Call 100 -93.75 2 -97.06 n/a n/a n/a
2025-11-12 2025-09-30 13F ETON PHARMACEUTICALS COM Call 1,600 -95.80 35 -93.73 n/a n/a n/a
2025-08-14 2025-06-30 13F ETON PHARMACEUTICALS COM Call 38,100 1,311.11 543 1,448.57 n/a n/a n/a
2025-05-14 2025-03-31 13F ETON PHARMACEUTICALS COM Call 2,700 -58.46 35 -59.30 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ETON PHARMACEUTICALS COM Call 6,500 96.97 87 352.63 n/a n/a n/a
2025-02-14 2024-12-31 13F ETON PHARMACEUTICALS COM Call 6,500 87 n/a n/a n/a
2024-11-14 2024-09-30 13F ETON PHARMACEUTICALS COM Call 3,300 175.00 20 533.33 n/a n/a n/a
2024-08-14 2024-06-30 13F ETON PHARMACEUTICALS COM Call 1,200 -92.05 4 -94.64 n/a n/a n/a
2024-05-10 2024-03-31 13F ETON PHARMACEUTICALS COM Call 15,100 -8.48 57 -22.22 n/a n/a n/a
2024-02-14 2023-12-31 13F ETON PHARMACEUTICALS COM Call 16,500 -21.43 72 -17.24 n/a n/a n/a
2023-11-09 2023-09-30 13F ETON PHARMACEUTICALS COM Call 21,000 3.96 88 24.29 n/a n/a n/a
2023-08-09 2023-06-30 13F ETON PHARMACEUTICALS COM Call 20,200 54.20 70 40.00 n/a n/a n/a
2023-05-12 2023-03-31 13F ETON PHARMACEUTICALS COM Call 13,100 -46.31 50 -26.47 n/a n/a n/a
2023-02-09 2022-12-31 13F ETON PHARMACEUTICALS COM Call 24,400 -9.29 68 21.43 n/a n/a n/a
2022-11-09 2022-09-30 13F ETON PHARMACEUTICALS COM Call 26,900 -73.34 56 -78.79 n/a n/a n/a
2022-08-11 2022-06-30 13F ETON PHARMACEUTICALS COM Call 100,900 -20.49 264 -52.26 n/a n/a n/a
2022-05-12 2022-03-31 13F ETON PHARMACEUTICALS COM Call 126,900 625.14 553 637.33 n/a n/a n/a
2022-02-11 2021-12-31 13F ETON PHARMACEUTICALS COM Call 17,500 19.86 75 1.35 n/a n/a n/a
2021-11-12 2021-09-30 13F ETON PHARMACEUTICALS COM Call 14,600 329.41 74 252.38 n/a n/a n/a
2021-08-10 2021-06-30 13F ETON PHARMACEUTICALS COM Call 3,400 21 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ETON PHARMACEUTICALS COM Put 400 0.00 7 -25.00 n/a n/a n/a
2025-11-12 2025-09-30 13F ETON PHARMACEUTICALS COM Put 400 300.00 9 700.00 n/a n/a n/a
2025-08-14 2025-06-30 13F ETON PHARMACEUTICALS COM Put 100 1 n/a n/a n/a
2025-05-14 2025-03-31 13F ETON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ETON PHARMACEUTICALS COM Put 1,000 0.00 13 116.67 n/a n/a n/a
2025-02-14 2024-12-31 13F ETON PHARMACEUTICALS COM Put 1,000 13 n/a n/a n/a
2024-11-14 2024-09-30 13F ETON PHARMACEUTICALS COM Put 1,000 900.00 6 n/a n/a n/a
2024-08-14 2024-06-30 13F ETON PHARMACEUTICALS COM Put 100 0.00 0 n/a n/a n/a
2024-05-10 2024-03-31 13F ETON PHARMACEUTICALS COM Put 100 0 n/a n/a n/a
2022-08-11 2022-06-30 13F ETON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F ETON PHARMACEUTICALS COM Put 7,000 0.00 31 3.33 n/a n/a n/a
2022-02-11 2021-12-31 13F ETON PHARMACEUTICALS COM Put 7,000 70.73 30 42.86 n/a n/a n/a
2021-11-12 2021-09-30 13F ETON PHARMACEUTICALS COM Put 4,100 21 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.